{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"tumor-predisposition-syndrome-3","columns":[{"gene":"","key":"population-e23a0faf201be6883c31","label":"Melanoma, cutaneous malignant, susceptibility to, 10","mondoId":"MONDO:0014368","onsetQualifier":null,"originColumnKey":"MONDO:0014368/OMIM:615848","originalViews":[{"key":"MONDO:0014368/OMIM:615848","label":"Melanoma, cutaneous malignant, susceptibility to, 10","scopeLabel":"OMIM:615848","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["242a78c0941d3df68f89555a073a209037e528fbe47120c98418c3e527f5c614","b88282c321031ece8ccc4d1450e1e6d18b1ca8f5c01986f01b44bddb51349d0c"],"recordQualifiers":{},"scopeLabel":"OMIM:615848","sourceIds":["OMIM:615848"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-e23a0faf201be6883c31"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0100245","HP:0002861"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":2,"sourceGroups":{"published":2}},"features":[{"hpoId":"HP:0100245","label":"Gastrointestinal desmoid tumor","primary":true},{"hpoId":"HP:0002861","label":"Melanoma","primary":true}],"ledeHtml":"Susceptibility to cutaneous malignant melanoma 10 (CMM10) is a genetic condition. This condition is characterized by an increased risk of developing various benign (non-cancerous) and malignant (cancerous) tumors. This includes a type of skin cancer called melanoma. The risk of developing these tumors increases as a person gets older. While tumors typically appear in adulthood, they can sometimes develop during childhood. The types of tumors can affect different parts of the body. This includes the skin, connective tissue, nerves, and blood. Additionally, this condition is characterized by having cells that live longer than usual. This may cause the cells to accumulate changes that potentially lead to cancer. CMM10 is caused by a mutation to the POT1 gene. This condition is inherited in an autosomal dominant pattern. This means single copy of the mutated gene is sufficient to cause the disorder. Not everyone who inherits the mutated POT1 gene will develop symptoms.","mondoId":"MONDO:0014368","node":{"canonicalSlug":"tumor-predisposition-syndrome-3","comparisons":[{"documentSha256":"d3c9b9c1e8e2c97320d121f654a3cd7296bdf1496e57a2e6e1a885b7058bd921","key":"legacy-tumor-predisposition-syndrome-3","kind":"legacy","label":"tumor predisposition syndrome 3","memberIds":["MONDO:0014368"],"mondoId":"MONDO:0014368","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/tumor-predisposition-syndrome-3.d3c9b9c1e8e2c97320d121f654a3cd7296bdf1496e57a2e6e1a885b7058bd921.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Tumor predisposition syndrome 3","originalSourceId":"OMIM:615848","paragraphs":["Susceptibility to cutaneous malignant melanoma 10 (CMM10) is a genetic condition. This condition is characterized by an increased risk of developing various benign (non-cancerous) and malignant (cancerous) tumors. This includes a type of skin cancer called melanoma. The risk of developing these tumors increases as a person gets older. While tumors typically appear in adulthood, they can sometimes develop during childhood. The types of tumors can affect different parts of the body. This includes the skin, connective tissue, nerves, and blood. Additionally, this condition is characterized by having cells that live longer than usual. This may cause the cells to accumulate changes that potentially lead to cancer. CMM10 is caused by a mutation to the POT1 gene. This condition is inherited in an autosomal dominant pattern. This means single copy of the mutated gene is sufficient to cause the disorder. Not everyone who inherits the mutated POT1 gene will develop symptoms."],"rawAttribution":"OMIM:615848","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:03:14Z","upstream":"PlainLanguagePilotV2-Jan24","url":"https://rarediseases.info.nih.gov/diseases/18582"},"ownColumnKeys":["population-e23a0faf201be6883c31"],"publication":"published","relationships":[{"kind":"parent","label":"susceptibility to familial cutaneous melanoma","mondoId":"MONDO:0024462","slug":"susceptibility-to-familial-cutaneous-melanoma"},{"kind":"parent","label":"glioma susceptibility","mondoId":"MONDO:0100242","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"multiple-identity-targets","source":"MedlinePlus","url":"https://medlineplus.gov/genetics/condition/melanoma"}],"translation":"pending"},"records":[{"frequencyKind":"reported","key":"242a78c0941d3df68f89555a073a209037e528fbe47120c98418c3e527f5c614","raw":{"aspect":"P","body_system":"neoplasm","disease_id":"OMIM:615848","disease_name":"Melanoma, cutaneous malignant, susceptibility to, 10","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0002861","is_excluded":false,"label":"Melanoma","onset_id":null,"reference":"PMID:24686849","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"b88282c321031ece8ccc4d1450e1e6d18b1ca8f5c01986f01b44bddb51349d0c","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:615848","disease_name":"Melanoma, cutaneous malignant, susceptibility to, 10","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0100245","is_excluded":false,"label":"Gastrointestinal desmoid tumor","onset_id":null,"reference":"PMID:37140166","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/18582\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0014368\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>PlainLanguagePilotV2-Jan24</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Susceptibility to cutaneous malignant melanoma 10 (CMM10) is a genetic condition. This condition is characterized by an increased risk of developing various benign (non-cancerous) and malignant (cancerous) tumors. This includes a type of skin cancer called melanoma. The risk of developing these tumors increases as a person gets older. While tumors typically appear in adulthood, they can sometimes develop during childhood. The types of tumors can affect different parts of the body. This includes the skin, connective tissue, nerves, and blood. Additionally, this condition is characterized by having cells that live longer than usual. This may cause the cells to accumulate changes that potentially lead to cancer. CMM10 is caused by a mutation to the POT1 gene. This condition is inherited in an autosomal dominant pattern. This means single copy of the mutated gene is sufficient to cause the disorder. Not everyone who inherits the mutated POT1 gene will develop symptoms.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/18582\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"tumor-predisposition-syndrome-3","sourceDocuments":[{"name":"GARD: Tumor predisposition syndrome 3","reviewed":null,"source_release":"2026-10-21T17:03:14Z","url":"https://rarediseases.info.nih.gov/diseases/18582"},{"name":"MONDO: tumor predisposition syndrome 3","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0014368"}],"sourceNote":"","synonyms":["CMM10","glioma susceptibility 9","glioma susceptibility type 9","GLM9","malignant glioma caused by mutation in POT1","melanoma, cutaneous malignant, susceptibility to, 10","melanoma, cutaneous malignant, susceptibility to, type 10","POT1 tumor predisposition","POT1-related tumor predisposition syndrome","POT1-TPD"],"takeawayHtml":"","title":"tumor predisposition syndrome 3"},"schemaVersion":1}
